Literature DB >> 23166541

The efficacy of immediate diet for reducing local adverse events of inhaled corticosteroid: a pilot study.

Myoung Kyu Lee1, Won Yeon Lee, Suk Joong Yong, Kye Chul Shin, Chong Whan Kim, Ji-Ho Lee, Saehyun Jung, Ye-Ryung Jung, Hyun Sik Kim, Tae-Sun Yu, Sang-Ha Kim.   

Abstract

BACKGROUND: Local adverse events associated with inhaled corticosteroid use, including dysphonia, pharyngitis and oral candidiasis, can affect adherence for treatment. 'Mouth rinsing method' has been used for reducing local adverse events, but it cannot ensure complete prevention. The goal of this pilot study was to identify whether the 'immediate diet method' can reduce local adverse events in a limited number of patients.
METHODS: The study was conducted in a total of 98 patients, who had been prescribed a medium-dose fluticasone propionate for the first time, from January to October in 2010. One training nurse had performed the education on how to use the inhaler, including the mouth rinsing method. And with follow-ups at one month intervals, any patient who experienced such adverse events were educated on the immediate diet method, having a meal within 5 minutes after using an inhaler and they were checked on any incurrence of adverse events with one month intervals for 2 months.
RESULTS: The mean age of patients was 65.9 years old. The local adverse events had incurred from 18.4% of the study subjects. When performed the follow-up observation in 18 patients with local adverse events after education on the immediate diet method, 14 patients (77.8%) had shown symptomatic improvements. Three of 4 patients did not show any improvement, in spite of implementing the immediate diet method. The other 1 patient did not practice the immediate diet method properly.
CONCLUSION: The immediate diet method may be useful in reducing the local adverse events, caused by the use of inhaled corticosteroid.

Entities:  

Keywords:  Candidiasis, Oral; Drug Toxicity; Dysphonia; Pharyngitis; Steroids

Year:  2012        PMID: 23166541      PMCID: PMC3492379          DOI: 10.4046/trd.2012.73.2.93

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  18 in total

1.  [Evaluation of an education program for patients with asthma who use inhalers].

Authors:  Jong Kyung Lee; Young Hee Yang
Journal:  J Korean Acad Nurs       Date:  2010-04       Impact factor: 0.984

Review 2.  Adverse effects of inhaled corticosteroids.

Authors:  D L Maxwell
Journal:  Biomed Pharmacother       Date:  1990       Impact factor: 6.529

3.  Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis.

Authors:  Gary S Rachelefsky; Yuning Liao; Rab Faruqi
Journal:  Ann Allergy Asthma Immunol       Date:  2007-03       Impact factor: 6.347

Review 4.  Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma.

Authors:  R Buhl
Journal:  Allergy       Date:  2006-05       Impact factor: 13.146

Review 5.  Glucocorticoid therapy for asthma: clinical pharmacology.

Authors:  S J Szefler
Journal:  J Allergy Clin Immunol       Date:  1991-08       Impact factor: 10.793

Review 6.  Complications of topical steroid therapy for asthma.

Authors:  J H Toogood
Journal:  Am Rev Respir Dis       Date:  1990-02

7.  Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus.

Authors:  L Knight; J Fletcher
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

8.  Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.

Authors:  Kai Richter; Frank Kanniess; Christian Biberger; Ruediger Nave; Helgo Magnussen
Journal:  J Clin Pharmacol       Date:  2005-02       Impact factor: 3.126

9.  A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients.

Authors:  R A Pauwels; F E Hargreave; P Camus; M Bukoski; E Ståhl
Journal:  Chest       Date:  1996-07       Impact factor: 9.410

10.  Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.

Authors:  Peter Brand; Bettina Hederer; George Austen; Helen Dewberry; Thomas Meyer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.